Dermata Therapeutics (DRMA) vs Redhill Biopharma (RDHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Dermata Therapeutics is the larger company by market cap ($5.3 million vs $5.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | DRMA | RDHL |
|---|---|---|
| Share price | $1.07 | $0.578 |
| Market cap | $5.30M | $5.14M |
| 1-day change | -4.46% | +21.94% |
| Forward P/E | — | 19.27 |
| EPS (TTM) | $-4.39 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.84 | $2.14 |
| 52-week low | $0.951 | $0.4351 |
| Distance from 52-week high | -77.89% | -72.99% |
| Average volume | 708.18K | 1.81M |
| Shares outstanding | 4.96M | 8.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
DRMA vs RDHL FAQ
Which is bigger, Dermata Therapeutics or Redhill Biopharma?
Dermata Therapeutics (DRMA) is larger, with a market capitalization of $5.30M compared with $5.14M for Redhill Biopharma (RDHL).
Are Dermata Therapeutics and Redhill Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.